NASDAQ: AZN
Astrazeneca Plc Stock

$58.85+0.75 (+1.29%)
Updated Jan 14, 2022
AZN Price
$58.85
Fair Value Price
N/A
Market Cap
$165.10B
52 Week Low
$46.48
52 Week High
$64.21
P/E
91.24x
P/B
4.15x
P/S
5.48x
PEG
1x
Dividend Yield
2.38%
Revenue
$32.82B
Earnings
$1.47B
Gross Margin
71.5%
Operating Margin
8.6%
Profit Margin
4.5%
Debt to Equity
1.69
Operating Cash Flow
$6B
Beta
0.55
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
Industry Average (42)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AZN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AZN ($58.85) is trading below its intrinsic value of $188.83, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
AZN is poor value based on its earnings relative to its share price (91.24x), compared to the US market average (35.21x)
Valuation
AZN is poor value based... subscribe to Premium to read more.
Valuation
There are 34 more AZN due diligence checks available for Premium users.

Valuation

AZN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
91.24x
Industry
26.36x
Market
35.21x
AZN is poor value based... subscribe to Premium to read more.
Valuation
AZN is poor value based... subscribe to Premium to read more.
Valuation

AZN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.15x
Industry
4.91x
AZN is good value based... subscribe to Premium to read more.
Valuation

AZN price to earnings growth (PEG)

For valuing profitable companies with growth potential
AZN is good value based... subscribe to Premium to read more.
Valuation

AZN's financial health

Profit margin

Revenue
$9.9B
Net Income
-$1.7B
Profit Margin
-16.7%
AZN's Earnings (EBIT) of $2.82B... subscribe to Premium to read more.
Financials
AZN's profit margin has decreased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$107.2B
Liabilities
$67.3B
Debt to equity
0.8
AZN's short-term assets ($26.69B) exceed... subscribe to Premium to read more.
Financials
AZN's long-term liabilities ($43.66B) exceed... subscribe to Premium to read more.
Financials
AZN's debt relative to shareholder... subscribe to Premium to read more.
Financials
AZN's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
$1.7B
Investing
-$10.5B
Financing
$142.0M
AZN's operating cash flow ($6.34B)... subscribe to Premium to read more.
Financials

Astrazeneca Stock FAQ

What is Astrazeneca's quote symbol?

(NASDAQ: AZN) Astrazeneca trades on the NASDAQ under the ticker symbol AZN. Astrazeneca stock quotes can also be displayed as NASDAQ: AZN.

What is the 52 week high and low for Astrazeneca (NASDAQ: AZN)?

(NASDAQ: AZN) Astrazeneca's 52-week high was $64.21, and its 52-week low was $46.48. It is currently -8.35% from its 52-week high and 26.61% from its 52-week low.

How much is Astrazeneca stock worth today?

(NASDAQ: AZN) Astrazeneca currently has 1,312,000,000 outstanding shares. With Astrazeneca stock trading at $58.85 per share, the total value of Astrazeneca stock (market capitalization) is $165.10B.

Astrazeneca stock was originally listed at a price of $18.00 in Dec 31, 1997. If you had invested in Astrazeneca stock at $18.00, your return over the last 24 years would have been 226.94%, for an annualized return of 5.06% (not including any dividends or dividend reinvestments).

How much is Astrazeneca's stock price per share?

(NASDAQ: AZN) Astrazeneca stock price per share is $58.85 today (as of Jan 14, 2022).

What is Astrazeneca's Market Cap?

(NASDAQ: AZN) Astrazeneca's market cap is $165.10B, as of Jan 18, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Astrazeneca's market cap is calculated by multiplying AZN's current stock price of $58.85 by AZN's total outstanding shares of 1,312,000,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.